Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
7
7 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- EG-007Phase 32 trials
Evergreen Therapeutics, Inc. · Advanced Endometrial Cancer
- Allogeneic umbilical cord mesenchymal stem cellsPhase 23 trials
Ever Supreme Bio Technology Co., Ltd. · COVID-19 Infection, Multiple Sclerosis, ST Elevation Myocardial Infarction
- EF-009Phase 21 trial
Everfront Biotech Co., Ltd. · Pancreatic Cancer
- EG-301Phase 21 trial
Evergreen Therapeutics, Inc. · Non-Exudative (Dry) Age-related Macular Degeneration (dAMD)
- EG-501EG-MNTP-01Phase 21 trial
Evergreen Therapeutics, Inc. · Neuropsychiatric Systemic Lupus Erythematosus, Systemic Lupus Erythematosus (SLE), Cognitive Impairment
- EVER001Phase 21 trial
Everest Medicines (China) Co.,Ltd. · Minimal Change Disease (MCD), IgA Nephropathy (IgAN), Focal Segmental Glomerulosclerosis (FSGS)
- EVM14Phase 21 trial
Everest Medicines (Beijing) Co., Ltd. · Selected Types of Solid Tumor
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.